Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation

Anticoagulation therapy significantly reduces the incidence of thromboembolic events in patients with atrial fibrillation (AF), and warfarin therapy at discharge is a class I–indicated drug in patients with ischemic stroke with persistent or paroxysmal AF without contraindications. The aim was to de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lewis, William R., Fonarow, Gregg C., LaBresh, Kenneth A., Cannon, Christopher P., Pan, Wenqin, Super, Dennis M., Sorof, Suzanne A., Schwamm, Lee H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086549/
https://ncbi.nlm.nih.gov/pubmed/19121441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.08.062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados